3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
2
Phase 3
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Breast
1
Conditions
Breast Neoplasms
67
Breast Neoplasms, Male
4
Neoplasm Metastasis
3
Neoplasms
2
Advanced Breast Cancer
2
Unilateral Breast Neoplasms
1
Sleep Wake Disorders
1
Recurrence
1
Ovarian Neoplasms
1
Hormone Receptor-Positive and HER2-Negative Advanced Breast Cancer
1
First Line Metastatic Breast Cancer
1
Fatigue
1
Carcinoma, Intraductal, Noninfiltrating
1
Bulbo-Spinal Atrophy, X-Linked
1
Breast Carcinoma In Situ
1
Breast Cancer Metastatic
1
Breast Cancer Female
1
Anatomic Stage II Breast Cancer AJCC v8
1
Interventions
fluzoparib
1
exemestane
1
dalpiciclib
1
Trastuzumab
1
Letrozole
1
Ga(III)-DOTATOC
1
Everolimus
1
Docetaxel
1
Aromatase Inhibitors
1
Anastrozole
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 3
×
Breast Cancer Metastatic
×
exemestane
×
Clear all
NCT02511639
2020-12-03
MAIN-A
Istituto Oncologico Veneto IRCCS
Phase 3
Completed
110 enrolled